Literature DB >> 22284622

Protective effects of incensole acetate on cerebral ischemic injury.

Arieh Moussaieff1, Jin Yu, Hong Zhu, Sebastiano Gattoni-Celli, Esther Shohami, Mark S Kindy.   

Abstract

The resin of Boswellia species is a major anti-inflammatory agent that has been used for centuries to treat various conditions including injuries and inflammatory conditions. Incensole acetate (IA), a major constituent of this resin, has been shown to inhibit NF-κB activation and concomitant inflammation, as well as the neurological deficit following head trauma. Here, we show that IA protects against ischemic neuronal damage and reperfusion injury in mice, attenuating the inflammatory nature of ischemic damage. IA given post-ischemia, reduced infarct volumes and improved neurological activities in the mouse model of ischemic injury in a dose dependent fashion. The protection from damage was accompanied by inhibition of TNF-α, IL-1β and TGF-β expression, as well as NF-κB activation following injury. In addition, IA is shown to have a therapeutic window of treatment up to 6h after ischemic injury. Finally, the protective effects of IA were partially mediated by TRPV3 channels as determined by the TRPV3 deficient mice and channel blocker studies. This study suggests that the anti-inflammatory and neuroprotective activities of IA may serve as a novel therapeutic treatment for ischemic and reperfusion injury, and as a tool in the ongoing research of mechanisms for neurological damage. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22284622      PMCID: PMC3294134          DOI: 10.1016/j.brainres.2012.01.001

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  40 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Current approaches to the pharmacologic treatment of anxiety disorders.

Authors:  David V Sheehan; Kathy Harnett Sheehan
Journal:  Psychopharmacol Bull       Date:  2007

Review 3.  Translational pharmacokinetics: challenges of an emerging approach to drug development in stroke.

Authors:  Andrew D Greenhalgh; Kayode Ogungbenro; Nancy J Rothwell; James P Galea
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-04-27       Impact factor: 4.481

4.  Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2.

Authors:  Suntaek Hong; Seunghwan Lim; Allen G Li; Chan Lee; Youn Sook Lee; Eun-Kyung Lee; Seok Hee Park; Xiao-Jing Wang; Seong-Jin Kim
Journal:  Nat Immunol       Date:  2007-03-25       Impact factor: 25.606

5.  TAK1 is recruited to the tumor necrosis factor-alpha (TNF-alpha) receptor 1 complex in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading to NF-kappaB activation.

Authors:  Marzenna Blonska; Prashant B Shambharkar; Masayuki Kobayashi; Dongyu Zhang; Hiroaki Sakurai; Bing Su; Xin Lin
Journal:  J Biol Chem       Date:  2005-10-31       Impact factor: 5.157

6.  Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection.

Authors:  Vivek Sharma; Mamata Mishra; Soumya Ghosh; Richa Tewari; Anirban Basu; Pankaj Seth; Ellora Sen
Journal:  Brain Res Bull       Date:  2007-02-28       Impact factor: 4.077

Review 7.  Neuroprotection and stroke: time for a compromise.

Authors:  Alan R Young; Carine Ali; Arnaud Duretête; Denis Vivien
Journal:  J Neurochem       Date:  2007-08-28       Impact factor: 5.372

8.  Incensole acetate: a novel neuroprotective agent isolated from Boswellia carterii.

Authors:  Arieh Moussaieff; Na'ama A Shein; Jeanna Tsenter; Savvas Grigoriadis; Constantina Simeonidou; Alexander G Alexandrovich; Victoria Trembovler; Yinon Ben-Neriah; Michael L Schmitz; Bernd L Fiebich; Eduardo Munoz; Raphael Mechoulam; Esther Shohami
Journal:  J Cereb Blood Flow Metab       Date:  2008-04-16       Impact factor: 6.200

Review 9.  An introduction to TRP channels.

Authors:  I Scott Ramsey; Markus Delling; David E Clapham
Journal:  Annu Rev Physiol       Date:  2006       Impact factor: 19.318

10.  Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury.

Authors:  D B Dubal; H Zhu; J Yu; S W Rau; P J Shughrue; I Merchenthaler; M S Kindy; P M Wise
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

View more
  10 in total

Review 1.  TRPV3: time to decipher a poorly understood family member!

Authors:  Bernd Nilius; Tamás Bíró; Grzegorz Owsianik
Journal:  J Physiol       Date:  2013-07-08       Impact factor: 5.182

Review 2.  Herbal medicines for ischemic stroke: combating inflammation as therapeutic targets.

Authors:  Yong Gu; Jianping Chen; Jiangang Shen
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-22       Impact factor: 4.147

Review 3.  Transient receptor potential channels in the vasculature.

Authors:  Scott Earley; Joseph E Brayden
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 4.  Avicenna's pharmacological approach to memory enhancement.

Authors:  Roja Rahimi; Shahrzad Irannejad; Maryam Noroozian
Journal:  Neurol Sci       Date:  2017-02-07       Impact factor: 3.307

5.  Inhibition of intracellular proton-sensitive Ca2+-permeable TRPV3 channels protects against ischemic brain injury.

Authors:  Xiaoling Chen; Jingliang Zhang; KeWei Wang
Journal:  Acta Pharm Sin B       Date:  2022-01-07       Impact factor: 14.903

6.  Nanoparticles for targeted delivery of antioxidant enzymes to the brain after cerebral ischemia and reperfusion injury.

Authors:  Xiang Yun; Victor D Maximov; Jin Yu; Hong Zhu; Alexey A Vertegel; Mark S Kindy
Journal:  J Cereb Blood Flow Metab       Date:  2013-02-06       Impact factor: 6.200

7.  The Effects of Incensole Acetate on Neuro-inflammation, Brain-Derived Neurotrophic Factor and Memory Impairment Induced by Lipopolysaccharide in Rats.

Authors:  Narges Marefati; Farimah Beheshti; Farzaneh Vafaee; Moslem Barabadi; Mahmoud Hosseini
Journal:  Neurochem Res       Date:  2021-06-26       Impact factor: 3.996

8.  Method parameters' impact on mortality and variability in mouse stroke experiments: a meta-analysis.

Authors:  Edvin Ingberg; Hua Dock; Elvar Theodorsson; Annette Theodorsson; Jakob O Ström
Journal:  Sci Rep       Date:  2016-02-15       Impact factor: 4.379

Review 9.  TRPV3 in Drug Development.

Authors:  Lisa M Broad; Adrian J Mogg; Elizabeth Eberle; Marcia Tolley; Dominic L Li; Kelly L Knopp
Journal:  Pharmaceuticals (Basel)       Date:  2016-09-09

Review 10.  Review of the Chemical Composition, Pharmacological Effects, Pharmacokinetics, and Quality Control of Boswellia carterii.

Authors:  Kai Huang; Yanrong Chen; Kaiyong Liang; Xiaoyan Xu; Jing Jiang; Menghua Liu; Fenghua Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-13       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.